title: Meisoindigo for the treatment of chronic myelogenous leukaemia.
authors: Z
authors: Z
authors: Xiao
authors: L
authors: L
authors: Qian
authors: B
authors: B
authors: Liu
authors: Y
authors: Y
authors: Hao
mesh_terms: D004359:Drug Therapy, Combination; D004365:Drugs, Chinese Herbal / Q000627:therapeutic use*; D006801:Humans; D006918:Hydroxyurea / Q000627:therapeutic use; D007211:Indoles / Q000627:therapeutic use*; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D019384:Nucleic Acid Synthesis Inhibitors / Q000627:therapeutic use; D016032:Randomized Controlled Trials as Topic; D012189:Retrospective Studies
chemical_list: D004365:Drugs, Chinese Herbal; D007211:Indoles; D019384:Nucleic Acid Synthesis Inhibitors; C047330:N-methylisoindigotin; D006918:Hydroxyurea